Anticoagulation reduced adverse clinical events in patients with atrial fibrillation at intermediate stroke risk, without an ...

Among adult veterans, oseltamivir treatment initiated within 6 hours of influenza diagnosis is associated with a reduced risk ...

Antiviral treatment started within 48 hours of symptom onset is linked to a reduced risk for hospitalization among pediatric ...

Visible hyperpigmentation may mask persistent erythema and should not be assumed to indicate resolved inflammation,’ ...

Over a median follow-up of 210.1 weeks, tirzepatide was found to be noninferior to dulaglutide, with an 8% lower rate of MACE-3. The estimated hazard ratio for time to first MACE was 0.92 (95.3% CI, 0 ...

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in ...

Vitamin B3 supplementation improves nailfold capillary patterns in patients with Raynaud phenomenon, with those with primary ...

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including ...

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially ...

The FDA has approved brepocitinib (Lisraya), an oral JAK inhibitor, for the treatment of dermatomyositis, a rare autoimmune ...

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Laser interstitial thermal therapy (LITT) demonstrates low complication rates in a study of nearly 800 patients with brain ...